Guidelines on the management of Paget's disease of bone.

[1]  I. B. Bender.  Paget's disease. , 2003, Journal of endodontics.

[2]  W. Murphy,et al.  Prevalence of Pelvic Paget's Disease of Bone in the United States , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  C. Hayes,et al.  Improvement of pagetic bone lesions with risedronate treatment: a radiologic study. , 2000, Bone.

[4]  M. Porter,et al.  Charnley low-friction arthroplasty for Paget's disease of the hip. , 2000, The Journal of arthroplasty.

[5]  C. Mautalen,et al.  Short‐Term Therapy with Oral Olpadronate in Active Paget's Disease of Bone , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  E. Siris.  Goals of treatment for paget's disease of bone , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  D. Gold,et al.  Factors associated with self‐rated health in patients with paget's disease of bone , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  P. Selby.  Pamidronate in the treatment of Paget's disease. , 1999, Bone.

[9]  F. Kaplan.  Severe orthopaedic complications of Paget's disease. , 1999, Bone.

[10]  A. Grauer,et al.  Ibandronate treatment in Paget's disease of bone. , 1999, Bone.

[11]  P. Richardson,et al.  Single infusion of zoledronate in Paget's disease of bone: a placebo-controlled, dose-ranging study. , 1999, Bone.

[12]  R. Eastell.  Biochemical markers of bone turnover in Paget's disease of bone. , 1999, Bone.

[13]  Jacques P. Brown,et al.  A randomized, double-blind comparison of risedronate and etidronate in the treatment of paget’s disease of bone , 1999 .

[14]  I. Reid,et al.  Alendronate in the treatment of Paget's disease of bone. , 1999, International journal of clinical practice. Supplement.

[15]  J. Reginster,et al.  Risedronate, a Highly Effective, Short-Term Oral Treatment for Paget's Disease: A Dose-Response Study , 1999, Calcified Tissue International.

[16]  E. Dennison,et al.  The Epidemiology of Paget's Disease in Britain: Is the Prevalence Decreasing? , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  J. Eisenberg,et al.  Views from funding agencies. Agency for Health Care Policy and Research. , 1998, Medical care.

[18]  Jacques P. Brown,et al.  Risedronate in the Treatment of Paget's Disease of Bone: An Open Label, Multicenter Study , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  P. Delmas,et al.  Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease. , 1998, Arthritis and rheumatism.

[20]  W. Fraser,et al.  A double-blind, multicentre, placebo-controlled study of tiludronate in Paget's disease of bone. , 1997, Postgraduate medical journal.

[21]  E. Siris,et al.  Antiresorptive Effect of a Single Infusion of Microgram Quantities of Zoledronate in Paget's Disease of Bone , 1997, Calcified Tissue International.

[22]  P. Delmas,et al.  MANAGEMENT OF PAGET’S DISEASE OF BONE , 1978 .

[23]  D. Gold,et al.  Paget's disease of bone and quality of life , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  W. Murphy,et al.  Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trial. , 1996, The American journal of medicine.

[25]  W. Murphy,et al.  Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone. , 1996, The Journal of clinical endocrinology and metabolism.

[26]  J. Reginster,et al.  Fortnightly Review: Paget's disease of bone: diagnosis and management , 1996, BMJ.

[27]  G. Fabry,et al.  The Ilizarov External Fixator for Treatment of Deformities in Paget's Disease , 1996, Clinical orthopaedics and related research.

[28]  I. Reid,et al.  Pamidronate treatment of the neurologic sequelae of pagetic spinal stenosis. , 1995, Archives of internal medicine.

[29]  N. P. O’Donnell,et al.  PAGET'S DISEASE: OCULAR COMPLICATIONS OF DISODIUM PAMIDRONATE TREATMENT , 1995, The British journal of clinical practice.

[30]  M. Dougados,et al.  Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone. , 1995, Arthritis and rheumatism.

[31]  R. Deulofeu,et al.  Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  F. Fraunfelder,et al.  Pamidronate disodium and possible ocular adverse drug reactions. , 1994, American journal of ophthalmology.

[33]  J. Devogelaer,et al.  Comparison of the acute biological action of injectable salmon calcitonin and an injectable and oral calcitonin analogue , 1994, Calcified Tissue International.

[34]  S. Adami,et al.  Effects of two oral doses of alendronate in the treatment of Paget's disease of bone. , 1994, Bone.

[35]  J. Highton,et al.  Uveitis associated with pamidronate. , 1994, Australian and New Zealand journal of medicine.

[36]  P. Filipponi,et al.  Effects of two different bisphosphonates on Paget's disease of bone: ICTP assessed. , 1994, Bone.

[37]  S. Adami,et al.  Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone. , 1994, Bone and mineral.

[38]  DavidC. Anderson,et al.  Pamidronate and Paget's disease , 1994, The Lancet.

[39]  S. Ralston,et al.  Mineralisation defects with pamidronate therapy for Paget's disease , 1993, The Lancet.

[40]  R. Watts,et al.  Treatment of Paget's disease of bone with single dose intravenous pamidronate. , 1993, Seminars in arthritis and rheumatism.

[41]  Kathleen M. Moran.  Acute Pain Management: Operative or Medical Procedures and Trauma. Clinical Practice Guideline. , 1993 .

[42]  S. Wimalawansa.  Long- and short-term side effects and safety of calcitonin in man: A prospective study , 1993, Calcified Tissue International.

[43]  A. Zwinderman,et al.  Improved treatment of paget's disease with dimethylaminohydroxypropylidene bisphosphonate , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[44]  I. Fogelman,et al.  Bone scintigraphy following intravenous pamidronate for Paget's disease of bone. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[45]  I. Fogelman,et al.  Treatment of Paget's disease by weekly infusions of 3-aminohydroxypropylidene-1,1-bisphosphonate (APD). , 1992, British journal of rheumatology.

[46]  J. Kanis.  Pathophysiology and Treatment of Paget's Disease of Bone , 1991 .

[47]  R. Price,et al.  Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responses , 1991, Clinical endocrinology.

[48]  R. Gittes.  Carcinoma of the prostate. , 1991, The New England journal of medicine.

[49]  D. Hosking,et al.  Treatment of paget's disease with intermittent low‐dose infusions of disodium pamidronate (APD) , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[50]  J. Mckillop,et al.  Serial bone scans in Paget's disease: Development of new lesions, natural variation in lesion intensity and nature of changes seen after treatment , 1990, Nuclear medicine communications.

[51]  J. Wilson-Macdonald,et al.  Total arthroplasty in Paget's disease of the hip. A clinical review and review of the literature. , 1990, Clinical orthopaedics and related research.

[52]  J. Kanis,et al.  Treatment of paget's disease of bone with aminohydroxybutylidene bisphosphonate , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[53]  Sandy Bidner,et al.  Femoral Fractures in Paget's Disease , 1989, Journal of orthopaedic trauma.

[54]  L. Mallette.  Successful treatment of resistant Paget's disease of bone with pamidronate. , 1989, Archives of internal medicine.

[55]  C. Löwik,et al.  Application of an in vitro model and a clinical protocol in the assessment of the potency of a new bisphosphonate , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[56]  D. Anderson,et al.  Relapse of osteoporosis circumscripta as a lytic ring after treatment of Paget's disease with intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate. , 1988, The British journal of radiology.

[57]  C. Gobelet,et al.  A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone. , 1988, The American journal of medicine.

[58]  G. Finerman,et al.  Stabilization of hearing loss in Paget's disease with calcitonin and etidronate. , 1988, Archives of otolaryngology--head & neck surgery.

[59]  D. Anderson,et al.  Paget's disease of the orbit: before and after APD. , 1987, British medical journal.

[60]  S. Papapoulos,et al.  Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD). , 1987, British medical journal.

[61]  J. Kanis,et al.  Duration of effect of oral diphosphonate therapy in Paget's disease of bone. , 1987, The Quarterly journal of medicine.

[62]  D. Wattie,et al.  Radiological assessment of Paget's disease of bone after treatment with the bisphosphonates EHDP and APD. , 1987, The British journal of radiology.

[63]  C. Mautalen,et al.  Intravenous aminopropylidene bisphosphonate (APD) in the treatment of paget's bone disease , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[64]  P. Delmas,et al.  Skeletal distribution and biochemical parameters of Paget's disease. , 1987, Clinical orthopaedics and related research.

[65]  D. Thiebaud,et al.  Paget's disease of bone treated in five days with AHPrBP (APD) per Os , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[66]  M. Zaaroor,et al.  Spinal cord compression in Paget's disease of bone with reference to sarcomatous degeneration and calcitonin treatment. , 1987, Surgical neurology.

[67]  S. Ralston,et al.  The effect of 1α‐hydroxyvitamin D3 on the mineralization defect in disodium etidronate‐treated paget's disease — a double‐blind randomized clinical study , 1987 .

[68]  D. Anderson,et al.  Lowdoseintravenous 3-amino-i- hydroxypropylide ne-1,1-bisphosph onate (APD)for thetreatment ofPaget's disease ofbone , 1986 .

[69]  F. Linthicum,et al.  Calcitonin as treatment for hearing loss in Paget's disease. , 1986, The American journal of otology.

[70]  P. Bannister,et al.  Recurrent hypercalcaemia in a young man with mono-ostotic Paget's disease. , 1986, Postgraduate medical journal.

[71]  M. Peacock,et al.  Osteomalacia in Paget's disease treated with short term, high dose sodium etidronate. , 1986, British medical journal.

[72]  E. Pauwels,et al.  Quantitative bone scintigraphy in Paget's disease treated with APD. , 1985, The British journal of radiology.

[73]  R. Altman.  Long-term follow-up of therapy with intermittent etidronate disodium in Paget's disease of bone. , 1985, The American journal of medicine.

[74]  R. Melick.  Treatment of Paget's disease of bone , 1985, The Medical journal of Australia.

[75]  J. Kanis,et al.  INTRAVENOUS CLODRONATE IN THE TREATMENT AND RETREATMENT OF PAGET'S DISEASE OF BONE , 1985, The Lancet.

[76]  J. Kanis,et al.  Carcinoma of the prostate: remission of paraparesis with inhibitors of bone resorption. , 1985, Postgraduate medical journal.

[77]  B. K. Prasad,et al.  Clinical experience with the use of two diphosphonates in the treatment of Paget's disease. , 1985, Annals of the rheumatic diseases.

[78]  S. Ralston,et al.  FOCAL OSTEOMALACIA DUE TO LOW-DOSE DIPHOSPHONATE THERAPY IN PAGET'S DISEASE , 1984, The Lancet.

[79]  M. Passeri,et al.  SIDE-EFFECTS OF SYNTHETIC SALMON AND HUMAN CALCITONIN , 1983, The Lancet.

[80]  G. Weisz.  Lumbar Spinal Canal Stenosis in Paget's Disease , 1983, Spine.

[81]  P. Dandona,et al.  Hypercalcaemia due to immobilization of a patient with Paget's disease of bone. , 1982, Postgraduate medical journal.

[82]  M. Chapuy,et al.  INTRAVENOUS ETIDRONATE FOR SPINAL CORD DYSFUNCTION DUE TO PAGET'S DISEASE , 1982, The Lancet.

[83]  J. Kanis,et al.  Spinal cord dysfunction in Paget's disease of bone. Has medical treatment a vascular basis? , 1981, The Journal of bone and joint surgery. British volume.

[84]  Hamilton Dv.  Hypercalcaemia in Paget's disease of bone. , 1981 .

[85]  J. Condon,et al.  Control of osteitis deformans using glucagon, calcitonin, and mithramycin. , 1981, Postgraduate medical journal.

[86]  J. Kanis,et al.  Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone. , 1980, Arthritis and rheumatism.

[87]  L. Herzberg,et al.  SPINAL-CORD SYNDROME DUE TO NON-COMPRESSIVE PAGET'S DISEASE OF BONE: A SPINAL-ARTERY STEAL PHENOMENON REVERSIBLE WITH CALCITONIN , 1980, The Lancet.

[88]  T. Ooi,et al.  Coexisting Paget's disease of bone and hyperparathyroidism. , 1980, The New Zealand medical journal.

[89]  L.,et al.  TREATMENT OF PAGET'S DISEASE WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.) , 1979, The Lancet.

[90]  S. Wallach,et al.  Neurologic disturbances in Paget disease of bone , 1979, Neurology.

[91]  I. Chalmers,et al.  Long term effectiveness of low dose mithramycin for Paget's disease of bone. , 1979, Arthritis and rheumatism.

[92]  M. Fuss,et al.  HYPERCALCÆMIA DUE TO IMMOBILISATION IN PAGET'S DISEASE OF BONE , 1978, The Lancet.

[93]  R. Altman,et al.  Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results. , 1977, Annals of internal medicine.

[94]  L. Solomon,et al.  Effect of calcitonin treatment on deafness due to Paget's disease of bone. , 1977, British medical journal.

[95]  M. Schumacher,et al.  Paget’s Disease with Spinal Cord Compression , 1977 .

[96]  F. Pygott.  Paget's disease of bone in 14 British towns , 1977 .

[97]  S. Bowring,et al.  A comparison of radiography and radioisotope scanning in the detection of Paget's disease and in the assessment of response to human calcitonin. , 1977, The British journal of radiology.

[98]  J. A. Strong,et al.  Treatment of Paget's disease of bone with porcine calcitonin: clinical and metabolic responses. , 1975, The Quarterly journal of medicine.

[99]  H. Wellman,et al.  Radiographs and scans in diagnosing symptomatic lesions of Paget's disease of bone (osteitis deformans). , 1974, Geriatrics.

[100]  R. Altman,et al.  Treatment of Paget disease of bone (osteitis deformans). Results of a one-year study with sodium etidronate. , 1974, JAMA.

[101]  S. Epstein.  Mithramycin in Paget's disease. , 1974, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[102]  R. Russell,et al.  Diphosphonates in Paget's disease. , 1974, Lancet.

[103]  J. Eisman,et al.  TREATMENT OF PAGET'S DISEASE OF BONE WITH PORCINE CALCITONIN , 1974, The Medical journal of Australia.

[104]  R. Altman,et al.  Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans). , 1973, The New England journal of medicine.

[105]  W. Ryan.  Mithramycin in Paget's disease of bone. , 1973, Lancet.

[106]  J. Evans,et al.  Mithramycin in the treatment of Paget's disease of bone. , 1972, The Journal of bone and joint surgery. American volume.

[107]  S. Wallach,et al.  The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone. , 1971, The Journal of clinical investigation.

[108]  C. Johnston,et al.  Effects of calcitonin in Paget's disease and polyostotic fibrous dysplasia. , 1970, The Journal of clinical endocrinology and metabolism.

[109]  Steinbach Hl.  Some roentgen features of Paget's disease. , 1961 .

[110]  D H COLLINS,et al.  PAGET'S DISEASE OF BONE: INCIDENCE AND SUBCLINICAL FORMS , 1956 .

[111]  E. Siris,et al.  A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group. , 1999, The American journal of medicine.

[112]  G. Gamble,et al.  Evidence for secular change in Paget's disease. , 1997, Bone.

[113]  C. Mautalen,et al.  Preliminary study of multiple increasing oral doses of dimethyl-APD on bone metabolism dynamics and safety profile. , 1994, Drugs under experimental and clinical research.

[114]  S. Nade,et al.  Outcome after fractures of the femur in Paget's disease. , 1992, The Australian and New Zealand journal of surgery.

[115]  A. Pontiroli,et al.  Intranasal and intramuscular human calcitonin in female osteoporosis and in Paget’s disease of bones: a pilot study , 1991, Journal of endocrinological investigation.

[116]  R. Mortimer,et al.  Single-dose intravenous pamidronate is effective alternative therapy for Paget's disease refractory to calcitonin. , 1991, Hormone research.

[117]  P. Burke,et al.  Improvement in the deformity of the face in Paget's disease treated with diphosphonates. , 1990, The Journal of bone and joint surgery. British volume.

[118]  J. Reginster,et al.  Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl) thiomethylene bisphosphonate, in the treatment of Paget's disease of bone. , 1988, Bone.

[119]  S. Ralston,et al.  The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study. , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[120]  C. Mautalen,et al.  Efficacy of the bisphosphonate APD in the control of Paget's bone disease. , 1985, Bone.

[121]  G. Finerman,et al.  Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP). , 1983, Clinical orthopaedics and related research.

[122]  P. Meunier,et al.  Effects of ethane-1 hydroxy-1, 1-diphosphonate (5 mg/kg/day dose) on quantitative bone histology in Paget's disease of bone. , 1981, Metabolic bone disease & related research.

[123]  E. Siris,et al.  Clinical and biochemical effects of EHDP in Paget's disease of bone: patterns of response to initial treatment and to long-term therapy. , 1981, Metabolic bone disease & related research.

[124]  J. Kanis,et al.  Paget's disease: improvement of spinal cord dysfunction with diphosphonates and calcitonin. , 1981, Metabolic bone disease & related research.

[125]  J. Kanis,et al.  Paget's disease of bone: diagnosis and management. , 1981, Metabolic bone disease & related research.

[126]  D. Heath.  The role of mithramycin in the management of Paget's disease. , 1981, Metabolic bone disease & related research.

[127]  T. B. Schwartz,et al.  Mithramycin and long remission of Paget's disease of bone. , 1980, Annals of internal medicine.

[128]  M. Fuss,et al.  Hypercalcaemia due to immobilisation in Paget's disease of bone. , 1978, Lancet.

[129]  R. Canfield,et al.  Diphosphonate therapy of paget's disease of bone. , 1977, The Journal of clinical endocrinology and metabolism.

[130]  W. Ryan.  Treatment of Paget's disease of bone with mithramycin. , 1977, Clinical orthopaedics and related research.

[131]  M. Schumacher,et al.  Paget's disease with spinal cord compression. Favourable course after decompression and calcitonin treatment in two cases. , 1977, European neurology.

[132]  H. Wellman,et al.  Skeletal scintimaging and radiography in the diagnosis and management of Paget's disease. , 1977, Clinical orthopaedics and related research.

[133]  P. Greenberg,et al.  Otological studies in patients with deafness due to Paget's disease before and after treatment with synthetic human calcitonin. , 1975, Acta oto-laryngologica.

[134]  R. Sherman,et al.  Roentgen diagnosis of Paget's disease (Osteitis deformans). The usual, the unusual, and the complications. , 1970, Dental radiography and photography.

[135]  H. Steinbach.  Some roentgen features of Paget's disease. , 1961, The American journal of roentgenology, radium therapy, and nuclear medicine.